[
    {
        "question": "In which of the following Arbiskov cells are seen?",
        "exp": "Granulocytic Sarcoma Also known as Choloroma or myeloblastoma. It is a hematopoietic stem cell tumour. It is an extramedullary tumor of immature granulocytic series cells. It is a localised tumour forming a mass in the skin of orbital & periorbital tissue due to infiltration of tissues by leukemic cells. It is most commonly associated with AML M2 Arbiskov cells are monocytes which can be seen in choloroma.",
        "cop": 3,
        "opa": "Myelodysplastic syndrome",
        "opb": "Multiple myeloma",
        "opc": "Granulocytic sarcoma",
        "opd": "Leukemia cutis",
        "subject_name": "Pathology",
        "topic_name": "Acute Myelogenous Leukemia",
        "id": "30510bbb-818d-4e5d-b2b3-ad3e7ef9a418",
        "choice_type": "single"
    },
    {
        "question": "Chromosomal translocation characteristic in acute promyelocytic leukemia is:",
        "exp": "In AML with the t(15; 17), acute promyelocytic leukemia (M3 stage), auer rods present (most common stage associated with DIC) t(8, 21) AML With maturation stage (M2 stage) t(16, 16) associated with best prognosis. Presence of \"FAGGOT CELLS\" is a characterstic feature of AML M3 (acute promyelocytic leukemia) Faggot cells are cluster of auer rods (shown in image below) All-trans retinoic acid (ATRA)- induce the neoplastic promyelocytes to differentiate into neutrophils rapidly.",
        "cop": 1,
        "opa": "t ( 15; 17)",
        "opb": "t ( 22; 9)",
        "opc": "t ( 21; 17)",
        "opd": "t ( 8; 21)",
        "subject_name": "Pathology",
        "topic_name": "Acute Myelogenous Leukemia",
        "id": "895d8a6c-69c9-4ee1-8757-546226f971e5",
        "choice_type": "single"
    },
    {
        "question": "A 15-year-old boy presented with one day history of bleeding gums, subconjunctival bleed and purpuric rash. Investigations revealed the following results: Hb-6. 4 gm/dL; TLC-26, 500/mm3 Platelet 35, 000 mm3; prothrombin time-20 sec with a control of 13 sec; paial thromboplastin time-50 sec; and Fibrinogen 10mg/dL. Peripheral smear was suggestive of acute myeloblastic leukemia. Which of the following is the most likely?",
        "exp": "The child presented with acute onset of bleeding, along with the following laboratory findings: Thrombocytopenia (35000/mm3 as compared to normal value of 1, 50, 000/mm3) Increased prothrombin time (20s as compared to control of 13s) Increased paial thromboplastin time (50s vs. normal 26-32s) Decreased fibrinogen (10 mg/dL vs. normal of 233- 496 mg/dl) These hematological abnormalities indicate disseminated intravascular coagulation. Most common form of AML associated with DIC is M3-AML (Acute promyelocytic leukemia). All-trans retinoic acid (ATRA), an analogue of vitamin A induce the neoplastic promyelocytes to differentiate into neutrophils rapidly and decrease chance of DIC. other agent useful is As. O3(arsenic trioxide).",
        "cop": 3,
        "opa": "Myeloblastic leukemia without maturation",
        "opb": "Myeloblastic leukemia with maturation",
        "opc": "Promyelocytic leukemia",
        "opd": "Myelomonocytic leukemia",
        "subject_name": "Pathology",
        "topic_name": "Acute Myelogenous Leukemia",
        "id": "654c428b-52c9-44ee-a565-c9731806768d",
        "choice_type": "single"
    },
    {
        "question": "A 40-year-old woman complains of fatigue and nausea of 3 months in duration. Physical examination reveals numerous pustules on the face, as well as splenomegaly and hepatomegaly. Laboratory studies show hemoglobin of 6. 3 g/dL and platelets of 50, 000/mL. A peripheral smear shows malignant cells with Auer rods (arrow). The patient develops diffuse purpura, bleeding from the gums, and laboratory features of disseminated intravascular coagulation (DIC). Which of the following is the appropriate diagnosis?",
        "exp": "In APL, the bone marrow is packed with tumor cells that have promyelocytic features, with abundant Auer rods. The presence of Auer rods excludes acute lymphoblastic leukemia (choice A), acute megakaryocytic leukemia (choice B), and chronic myelogenous leukemia (choice D). DIC is not characteristic of the other choices. Diagnosis: Acute promyelocytic leukemia",
        "cop": 3,
        "opa": "Acute lymphoblastic leukemia",
        "opb": "Acute megakaryocytic leukemia",
        "opc": "Acute promyelocytic leukemia",
        "opd": "Chronic myelogenous leukemia",
        "subject_name": "Pathology",
        "topic_name": "Acute Myelogenous Leukemia",
        "id": "bf487744-52f3-4ac8-8c72-260a378b68f2",
        "choice_type": "single"
    },
    {
        "question": "Which of the following is not compatible with a diagnosis of chronic myelomonocytic leukemia?",
        "exp": "WHO (2017) Diagnostic criteria of CMML: Persistent peripheral blood monocytosis (>= 1 x 109/L) with monocytes accounting for >= 10% of the leukocytes WHO criteria for BCR-ABL1--positive chronic myeloid leukaemia, primary myelofibrosis, polycythaemia vera and essential thrombocythaemia are not met No rearrangement of PDGFRA, PDGFRB or FGFR1 and no PCM1-JAK2 Blasts (incl. promonocytes) constitute < 20% of the cells in the peripheral blood and bone marrow Dysplasia involving >= 1 myeloid lineages or. If myelodysplasia is absent or minimal, criteria 1-4 are met and:- an acquired, clonal cytogenetic or molecular genetic abnormality is present in haematopoietic cells, or- the monocytosis has persisted for >=3 months and all other causes of monocytosis (e. g. malignancy, infection, and inflammation) have been excluded",
        "cop": 3,
        "opa": "Peripheral blood monocytosis more than 1 x 109/L",
        "opb": "Absence of Philadelphia chromosome",
        "opc": "More than 20% blasts in blood or bone marrow",
        "opd": "Myelodysplasia",
        "subject_name": "Pathology",
        "topic_name": "Acute Myelogenous Leukemia",
        "id": "b9812c60-3923-4a0f-a78f-f18c2ac9c166",
        "choice_type": "single"
    },
    {
        "question": "AML with adverse prognosis is:",
        "exp": "Prognostic factors in AML A. Favourable prognostic factors B. Unourable prognostic factors Age <40 years AML without antecedent MDS/MPD Blast cells with Auer rods TLC <25 x 109/L FAB subtype-AML-M2, M3, M4 High WBC Count> 100 x 109/L AML with preceding MDS/MPD Extremes of age<2years and >55years -7/7q-* Extramedullary disease in AML-M5 Presence of CNS involvement FAB subtype - AML - M0, M6, M7 t (15; 17) in AML- M3-PML/RARA +ve t (8; 21) in AML- M2 Ivn (16) in AML - MYH11 mutation NPM1 mutations without FLT3 mutations Biallelic CEBPA gene mutations. MLLT3 -KMT2A (intermediate prognosis) Trisomy 8 del (7q) del (5q) 11q23-MLL +ve 3q21 Del (7q) Expression of MDR-1 gene (multidrug gene) 3q26 t(9; 11) complex Karyotypes/ Normal cytogenetic inv3; t(3; 3) t(6: 9) FLT -3 mutation (ITD are worse than TKD) MLL gene rearrangement RAS gene mutations KIJ gene mutationsp p53 gene mutations ERG gene mutations MN1 gene mutations RUNX1 mutation BCR-ABL 1 mutation",
        "cop": 4,
        "opa": "t(8; 21)",
        "opb": "t(15; 17)",
        "opc": "Normal cytogenetics",
        "opd": "Del 7q",
        "subject_name": "Pathology",
        "topic_name": "Acute Myelogenous Leukemia",
        "id": "b8007e4a-1da8-4fae-9304-74d73b0d1970",
        "choice_type": "single"
    }
]